Company archive
Read that company's published results in release order, newest first.
Showing 1-7 of 7 published briefings.
The earnings step-up was concentrated in the smaller Medical services segment while operating cash flow grew only 3.7% and free cash flow fell.
Published 29 May 2026
Read briefingWorking capital absorption and a near-tripling of capex weakened cash conversion even as reported earnings grew above the historical range.
Published 22 April 2026
Read briefingNPAT was flat at $5.6m and returns sat below the historical baseline as a $4.9m receivables drawdown drove most of the cash uplift.
Published 22 April 2026
Read briefingOperating cash held flat but reserves fell $34.8m and borrowings rose 48.5%, with the final dividend cut 42.9% to 2.0 cents.
Published 22 April 2026
Read briefingThe 29.5% headline revenue drop reflects the Community Health divestment, but continuing operations show eroding margins and a balance sheet that no
Published 22 April 2026
Read briefingThe discontinued operation supplied two-thirds of reported NPAT while operating cash flow fell 30.3% and continuing EBIT dropped 29%.
Published 22 April 2026
Read briefingThe dominant pharmacy segment lost revenue share and earnings while a 30.3% effective tax rate clipped NPAT growth to 17.5%.
Published 22 April 2026
Read briefingGet full NZX result briefings by email as new coverage is published.